SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as it approaches its all-time high, sparking excitement about a potential breakout and new price discovery. Community members are actively discussing price targets, longing liquidations, and the potential for significant gains, fueling both bullish sentiment and speculation about an incoming supply shock. The conversation also includes the broader implications for related stocks and the overall crypto market.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its potential for growth and freedom within the crypto space. Discussions highlight its natural and steady progress, with comparisons being drawn to Bitcoin. Community members are sharing links to the official website and social media.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as investors discuss its potential to break the $40 resistance level, fueled by strong growth and expansion, including recent entry into the US market; the community anticipates a potential breakout and Nasdaq relisting, with some expressing frustration over the stock's range-bound movement.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to an army memo revealing security flaws in its battlefield communication system, sparking debate about its valuation and government contracts. While some investors express concern and anticipate a price drop, others dismiss the news as a buying opportunity and reiterate confidence in the company's long-term potential. Community discussions revolve around whether the identified issues are already resolved and the extent to which they impact Palantir's future prospects.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to recent news of a $5.7 million sale of two quantum computers, sparking enthusiasm and debate within the community about the company's valuation and future prospects in the quantum computing sector. Community members are actively discussing the potential for further gains, a possible short squeeze, and the overall hype surrounding quantum computing stocks, while also weighing the risks of a potential pullback.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending downwards, triggering intense debate among traders regarding support levels and potential bottom. Community sentiment is divided, with bears citing concerns over margins, expiring tax credits and technical indicators, while bulls are hoping for a bounce and citing long-term potential. Recent price action has led to increased volatility and discussions around potential manipulation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders debate the sustainability of the current market rally amid government shutdown concerns and upcoming economic data. Community discussions revolve around identifying potential entry points for both bullish and bearish positions, with some anticipating a significant pullback while others remain confident in the upward trend. Increased volatility and sector rotations are also being closely monitored.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics is trending as the stock makes a strong move, with community members pointing to potential catalysts and a possible short squeeze. Discussion revolves around the company's potential, particularly its infrastructure and data center applications within the robotics sector, with some speculating about future partnerships and a new robot reveal. Investors are closely watching key price levels and expressing bullish sentiment for the stock's long-term prospects.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending as community members discuss its potential to close the market cap gap with competitor Joby ($JOBY), fueled by upcoming milestones like piloted VTOL flights and airworthiness certification. Bullish sentiment is further supported by news of partnerships, defense contracts, and analyst upgrades, leading to speculation about a significant price increase. Some traders point to high short interest as a catalyst for a potential squeeze.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing volatility, with community members debating whether recent dips are buying opportunities or signals of a larger pullback. Some traders point to technical indicators and the government shutdown as reasons for caution, while others highlight the market's overall bullish trend and the potential for AI to drive further gains. Discussions also involve concerns about overvaluation, margin debt, and the impact of economic data.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Arvinas Inc. (ARVN) fell 4% on Thursday as Wall Street sounded contradicting opinions on the future of its investigational drug Vepdegestrant.Wells Fargo believes Pfizer's (PFE) waning interest in Vepdegestrant could lead to Arvinas getting it back, but given where the stock is trading, this seems priced in. The firm noted that Arvinas won't launch the drug solo and added that with runway to the second half of 2028, focus shifts to its early-stage pipeline, which can create value.Arvinas announced a global collaboration with Pfizer for the co-development and co-commercialization of Vepdegestrant in July 2021. Wells lowered its price target on <a href="https://stocktwits.com/symbol/ARVN">Arvinas</a> to $16 from $19 while keeping an ‘Overweight’ rating on the shares.&nbsp;On Stocktwits, retail sentiment around Arvinas fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:626/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_10_00_16_AM_png_a0b59de82a.webp" alt="ARVN's Sentiment Meter and Message Volume as of 10 a.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="626" height="61"><figcaption>ARVN's Sentiment Meter and Message Volume as of 10 a.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>H.C. Wainwright, however, raised its price target on Arvinas to $24 from $18 while keeping a ‘Buy’ rating on the shares. The firm sees a path forward for Vepdegestrant and cited the company's pipeline development and progress for the target increase.Arvinas and its partner Pfizer submitted a new drug application for Vepdegestrant to the U.S. Food and Drug Administration in June for the treatment of certain types of advanced or metastatic breast cancer previously treated with endocrine-based therapy.The application was based on data from a late-stage trial that evaluated Vepdegestrant versus the popular breast cancer medicine Fulvestrant. While the trial demonstrated improvement in median progression-free survival (PFS) compared to Fulvestrant, it did not reach statistical significance.In the second quarter, Arvinas recorded a revenue of $22.4 million, down from $76.5 million in the corresponding quarter of 2024. The company pegged the drop in part to a fall in revenue from the agreement with Pfizer related to the removal of certain late-stage combination trials of Vepdegestrant with Pfizer’s investigational drugs from the development plan.ARVN stock is down by 68% this year and by about 75% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/toyota-warns-higher-us-tariff-impact-for-fy26/chrmEbQRdd6">Toyota Warns Higher US Tariff Impact For FY26: Retail Sees No Reason To Cheer</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Wall Street Has Mixed Opinions On Future Of Arvinas’ Investigational Drug: Retail’s Got A Cautious Approach

While Wells Fargo remains pessimistic on Vepdegestrant’s future, H.C. Wainwright is hopeful. 

Equity

While Wells Fargo remains pessimistic on Vepdegestrant’s future, H.C. Wainwright is hopeful. 


Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y

CPRX beats Q2 earnings and revenue estimates as Firdapse and Agamree drive strong top-line growth.

Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth

ACAD reports encouraging second-quarter results as earnings and revenues beat estimates, driven by year-over-year growth in Nuplazid and Daybue sales. 

Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles

NVO's Q2 earnings beat but revenues miss estimates as Wegovy and Ozempic face U.S. setbacks and rising competition.

BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark

Beam Therapeutics posts narrower second-quarter loss but misses revenue estimates. The company provides updates on pipeline progress.

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Recursion Pharmaceuticals stock drops as Q2 loss widens and pipeline shake-up continues, despite revenues boost from Sanofi milestone.

Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

RARE posts a narrower Q2 loss and 13% revenue growth as demand rises across all four marketed rare disease drugs.

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises

Esperion posts narrower-than-expected second-quarter loss with revenues rising 12% and product sales jumping 42% year over year.

Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates

Arvinas (ARVN) delivered earnings and revenue surprises of +3.45% and -53.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised

Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Arvinas Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

ARVN
Arvinas Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ARVN News

ARVN Arvinas Inc